Home › Funds › BVF INC/IL › KYMR
BVF INC/IL position in KYMR
KYMERA THERAPEUTICS INC · Health Care
BVF INC/IL reported holding 3,872,052 shares of KYMR (KYMERA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$444.0M, representing 11.35% of its reported portfolio and ranking #2 among its reported holdings. BVF INC/IL has disclosed KYMR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BVF INC/IL's KYMR position evolved
BVF INC/IL first disclosed a stake in KYMR in Q3 2023 at 4,739,004 shares (US$65.9M). The position peaked in Q1 2026 at 5,502,710 shares, worth US$458.3M. Across 12 filings, BVF INC/IL increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 3,872,052 shares valued at US$444.0M — a reduction of -1,630,658 shares quarter over quarter.. Notable position changes include a 30% trim in Q2 2026 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.74M | $65.87M | New |
| Q4 2023 | 5.16M | $131.42M | Add |
| Q1 2024 | 5.16M | $207.50M | Hold |
| Q2 2024 | 5.16M | $154.08M | Hold |
| Q3 2024 | 5.16M | $244.31M | Hold |
| Q4 2024 | 5.16M | $207.66M | Hold |
| Q1 2025 | 5.16M | $141.28M | Hold |
| Q2 2025 | 5.50M | $240.14M | Add |
| Q3 2025 | 5.50M | $311.45M | Hold |
| Q4 2025 | 5.50M | $428.17M | Hold |
| Q1 2026 | 5.50M | $458.32M | Hold |
| Q2 2026 | 3.87M | $444.01M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KYMR and 13F data
KYMR (KYMERA THERAPEUTICS INC) is a Health Care company. 57 other funds we track also report a position in KYMR — the largest reported positions include BAKER BROS. ADVISORS LP (US$992.7M), Avoro Capital Advisors LLC (US$857.1M), T. Rowe Price Investment Management, Inc. (US$717.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KYMR
- BAKER BROS. ADVISORS LP 8.66M sh · $992.73M · Q2 2026
- Avoro Capital Advisors LLC 7.47M sh · $857.13M · Q2 2026
- T. Rowe Price Investment Management, Inc. 6.26M sh · $717.52M · Q2 2026
- Siren, L.L.C. 2.94M sh · $336.65M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 2.85M sh · $326.53M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 919.23K sh · $105.41M · Q2 2026
- Merck & Co., Inc. 772.16K sh · $88.54M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 740.87K sh · $84.96M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 504.21K sh · $57.81M · Q2 2026
- Rock Springs Capital Management LP 453.16K sh · $51.96M · Q2 2026
- Boxer Capital Management, LLC 429.10K sh · $49.20M · Q2 2026
- BRAIDWELL LP 378.16K sh · $43.36M · Q2 2026
FAQ
How long has BVF INC/IL held KYMR?
BVF INC/IL has disclosed KYMR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is BVF INC/IL's current position in KYMR?
As of Q2 2026, BVF INC/IL holds 3.87M shares of KYMR (KYMERA THERAPEUTICS INC), valued at $444.01M, representing 11.35% of its reported portfolio and ranking #2.
Has BVF INC/IL been buying or selling KYMR?
In the latest 13F filing (Q2 2026), BVF INC/IL reduced its position in KYMR. The position peaked in Q1 2026 at 5.50M shares.
Which other funds hold KYMR?
Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, T. Rowe Price Investment Management, Inc., among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.